Corrigendum to Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy [Mol Metab, 4, 6, (2015), 493-506] DOI: 10.1016/j.molmet.2015.04.001;Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy

Molecular Metabolism

Volumn 4, Issue 6, 2015, Pages 493-506

  Katunga, Lalage A ^a,b   Gudimella, Preeti ^a   Efird, Jimmy T ^b   Abernathy, Scott ^a   Mattox, Taylor A ^a   Beatty, Cherese ^a   Darden, Timothy M ^a   Thayne, Kathleen A ^a   Alwair, Hazaim ^b   Kypson, Alan P ^b   Virag, Jitka A ^a   Anderson, Ethan J ^a,b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Glutathione peroxidase 4; Human heart; Inflammation; Lipid peroxidation; Mitochondria; Obesity

Indexed keywords

4 HYDROXYNONENAL; ALDEHYDE; CARBONYL DERIVATIVE; FAT; GLUCOSE; LIPID PEROXIDE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; SUCROSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; CARDIOMYOPATHY; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE EXACERBATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSLIPIDEMIA; FATTY ACID OXIDATION; FATTY LIVER; FEMALE; FOOD INTAKE; GLUCOSE INTOLERANCE; HAPLOINSUFFICIENCY; HEART; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART SURGERY; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; LIPID DIET; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC PARAMETERS; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; UPREGULATION; WILD TYPE;

MUS;

EID: 84929946877     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.06.005     Document Type: Erratum

References (102)

1. Ng M., Fleming T., Robinson M., Thomson B., Graetz N., Margono C., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet 2014, 384(9945):766-781. 10.1016/S0140-6736(14)60460-8.
2. Danaei G., Finucane M.M., Lu Y., Singh G.M., Cowan M.J., Paciorek C.J., et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378(9785):31-40. 10.1016/S0140-6736(11)60679-X.
3. Kiencke S., Handschin R., von Dahlen R., Muser J., Brunner-Larocca H.P., Schumann J., et al. Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome. European Journal of Heart Failure 2010, 12(9):951-957. 10.1093/eurjhf/hfq110.
4. Selvin E., Lazo M., Chen Y., Shen L., Rubin J., McEvoy J.W., et al. Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage. Circulation 2014, 130(16):1374-1382. 10.1161/CIRCULATIONAHA.114.010815.
5. Khan J.N., Wilmot E.G., Leggate M., Singh A., Yates T., Nimmo M., et al. Subclinical diastolic dysfunction in young adults with type 2 diabetes mellitus: a multiparametric contrast-enhanced cardiovascular magnetic resonance pilot study assessing potential mechanisms. European Heart Journal-Cardiovascular Imaging 2014, jeu121.
6. Porcar-Almela M., Codoner-Franch P., Tuzon M., Navarro-Solera M., Carrasco-Luna J., Ferrando J. Left ventricular diastolic function and cardiometabolic factors in obese normotensive children. Nutrition, Metabolism & Cardiovascular Diseases 2015, 25(1):108-115. 10.1016/j.numecd.2014.08.013.
7. Catala A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chemistry and Physics of Lipids 2009, 157(1):1-11. 10.1016/j.chemphyslip.2008.09.004.
8. Guichardant M., Chantegrel B., Deshayes C., Doutheau A., Moliere P., Lagarde M. Specific markers of lipid peroxidation issued from n-3 and n-6 fatty acids. Biochemical Society Transactions 2004, 32(Pt 1):139-140. doi: 10.1042/.
9. Guichardant M., Bacot S., Moliere P., Lagarde M. Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites. Prostaglandins Leukotrienes and Essential Fatty Acids 2006, 75(3):179-182. 10.1016/j.plefa.2006.05.006.
10. Refsgaard H.H., Tsai L., Stadtman E.R. Modifications of proteins by polyunsaturated fatty acid peroxidation products. Proceedings of National Academy of Sciences USA 2000, 97(2):611-616.
11. West J.D., Marnett L.J. Alterations in gene expression induced by the lipid peroxidation product, 4-hydroxy-2-nonenal. Chemical Research in Toxicology 2005, 18(11):1642-1653.
12. Uchida K. 4-hydroxy-2-nonenal: a product and mediator of oxidative stress. Progress in Lipid Research 2003, 42(4):318-343.
13. Uchida K. Role of reactive aldehyde in cardiovascular diseases. Free Radical Biology and Medicine 2000, 28(12):1685-1696.
14. LoPachin R.M., Gavin T., Petersen D.R., Barber D.S. Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chemical Research in Toxicology 2009, 22(9):1499-1508. doi: 10.1021/tx900147g.
15. Januszewski A.S., Alderson N.L., Metz T.O., Thorpe S.R., Baynes J.W. Role of lipids in chemical modification of proteins and development of complications in diabetes. Biochemical Society Transactions 2003, 31(Pt 6):1413-1416. doi: 10.1042/.
16. Blair I.A. DNA adducts with lipid peroxidation products. Journal of Biological Chemistry 2008, 283(23):15545-15549. doi: 10.1074/jbc.R700051200.
17. Siems W., Grune T. Intracellular metabolism of 4-hydroxynonenal. Molecular Aspects of Medicine 2003, 24(4-5):167-175.
18. Chavez J.D., Wu J., Bisson W., Maier C.S. Site-specific proteomic analysis of lipoxidation adducts in cardiac mitochondria reveals chemical diversity of 2-alkenal adduction. Journal of Proteomics 2011, 10.1016/j.jprot.2011.03.031.
19. Minko I.G., Kozekov I.D., Harris T.M., Rizzo C.J., Lloyd R.S., Stone M.P. Chemistry and biology of DNA containing 1, N(2)-deoxyguanosine adducts of the alpha,beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chemical Research in Toxicology 2009, 22(5):759-778. doi: 10.1021/tx9000489.
20. Maier C.S., Chavez J., Wang J., Wu J. Protein adducts of aldehydic lipid peroxidation products identification and characterization of protein adducts using an aldehyde/keto-reactive probe in combination with mass spectrometry. Methods in Enzymology 2010, 473:305-330. 10.1016/S0076-6879(10)73016-0.
21. Nair J., Barbin A., Velic I., Bartsch H. Etheno DNA-base adducts from endogenous reactive species. Mutation Research 1999, 424(1-2):59-69.
22. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991, 11(1):81-128.
23. Shimozu Y., Hirano K., Shibata T., Shibata N., Uchida K. 4-hydroperoxy-2-nonenal is not just an intermediate but a reactive molecule that covalently modifies proteins to generate unique intramolecular oxidation products. Journal of Biological Chemistry 2011, 286(33):29313-29324. 10.1074/jbc.M111.255737.
24. Paradies G., Petrosillo G., Pistolese M., Di Venosa N., Serena D., Ruggiero F.M. Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion. Free Radical Biology and Medicine 1999, 27(1-2):42-50.
25. Fry M., Green D.E. Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain. Journal of Biological Chemistry 1981, 256(4):1874-1880.
26. Chicco A.J., Sparagna G.C. Role of cardiolipin alterations in mitochondrial dysfunction and disease. American Journal of Physiology - Cell Physiology 2007, 292(1):C33-C44. 10.1152/ajpcell.00243.2006.
27. Anderson E.J., Katunga L.A., Willis M.S. Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart. Clinical and Experimental Pharmacology and Physiology 2012, 39(2):179-193. 10.1111/j.1440-1681.2011.05641.x. 10.1111/j.1440-1681.2011.05641.x.
28. Imai H., Hirao F., Sakamoto T., Sekine K., Mizukura Y., Saito M., et al. Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene. Biochemical and Biophysical Research Communications 2003, 305(2):278-286.
29. Brigelius-Flohe R., Maiorino M. Glutathione peroxidases. Biochimica et Biophysica Acta 2012, 10.1016/j.bbagen.2012.11.020. 10.1016/j.bbagen.2012.11.020.
30. Brigelius-Flohe R. Tissue-specific functions of individual glutathione peroxidases. Free Radical Biology and Medicine 1999, 27(9-10):951-965.
31. Maiorino M., Thomas J.P., Girotti A.W., Ursini F. Reactivity of phospholipid hydroperoxide glutathione peroxidase with membrane and lipoprotein lipid hydroperoxides. Free radical research communications 1991, 1(12-13 Pt):131-135.
32. Maiorino M., Gregolin C., Ursini F. Phospholipid hydroperoxide glutathione peroxidase. Methods in Enzymology 1990, 186:448-457.
33. Scimeca M.S., Lisk D.J., Prolla T., Lei X.G. Effects of gpx4 haploid insufficiency on GPx4 activity, selenium concentration, and paraquat-induced protein oxidation in murine tissues. Experimental Biology and Medicine(Maywood) 2005, 230(10):709-714.
34. Morgan E.E., Faulx M.D., McElfresh T.A., Kung T.A., Zawaneh M.S., Stanley W.C., et al. Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction. American Journal of Physiology-HeartandCirculatory Physiology 2004, 287(5):H2049-H2053. doi: 287/5/H2049 [pii] 10.1152/ajpheart.00393.2004.
35. Ran Q., Van Remmen H., Gu M., Qi W., Roberts L.J., Prolla T., et al. Embryonic fibroblasts from Gpx4+/- mice: a novel model for studying the role of membrane peroxidation in biological processes. Free Radical Biology and Medicine 2003, 35(9):1101-1109.
36. Ruperez A.I., Olza J., Gil-Campos M., Leis R., Mesa M.D., Tojo R., et al. Association of genetic polymorphisms for glutathione peroxidase genes with obesity in spanish children. Journal of Nutrigenetics and Nutrigenomics 2014, 7(3):130-142. doi: 000368833.
37. Polonikov A.V., Vialykh E.K., Churnosov M.I., Illig T., Freidin M.B., Vasil'eva O.V., et al. The C718T polymorphism in the 3'-untranslated region of glutathione peroxidase-4 gene is a predictor of cerebral stroke in patients with essential hypertension. Hypertension Research 2012, 35(5):507-512. doi: 10.1038/hr.2011.213.
38. Crosley L.K., Bashir S., Nicol F., Arthur J.R., Hesketh J.E., Sneddon A.A. The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. Molecular Nutrition & Food Research 2013, 57(12):2185-2194. doi: 10.1002/mnfr.201300216.
39. Du X.H., Dai X.X., Xia Song R., Zou X.Z., Yan Sun W., Mo X.Y., et al. SNP and mRNA expression for glutathione peroxidase 4 in kashin-beck disease. British Journal of Nutrition 2012, 107(2):164-169. 10.1017/S0007114511002704.
40. Villette S., Kyle J.A., Brown K.M., Pickard K., Milne J.S., Nicol F., et al. Anovel single nucleotide polymorphism in the 3' untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells, Molecules & Diseases 2002, 29(2):174-178. doi: S1079979602905565.
41. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440(7086):944-948. doi: nature04634.
42. Anderson E.J., Lustig M.E., Boyle K.E., Woodlief T.L., Kane D.A., Lin C.T., et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. Journal of Clinical Investigation 2009, 119(3):573-581. doi: 10.1172/JCI37048.
43. Yant L.J., Ran Q., Rao L., Van Remmen H., Shibatani T., Belter J.G., et al. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radical Biology and Medicine 2003, 34(4):496-502.
44. Ran Q., Liang H., Ikeno Y., Qi W., Prolla T.A., Roberts L.J., et al. Reduction in glutathione peroxidase 4 increases life span through increased sensitivity to apoptosis. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2007, 62(9):932-942. doi: 62/9/932.
45. Meplan C., Crosley L.K., Nicol F., Horgan G.W., Mathers J.C., Arthur J.R., et al. Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex. American Journal of Clinical Nutrition 2008, 87(4):1019-1027.
46. Qin F., Siwik D.A., Luptak I., Hou X., Wang L., Higuchi A., et al. The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice. Circulation 2012, 125(14):1757-1764. S1-6. 10.1161/CIRCULATIONAHA.111.067801.
47. Burgmaier M., Sen S., Philip F., Wilson C.R., Miller C.C., Young M.E., et al. Metabolic adaptation follows contractile dysfunction in the heart of obese zucker rats fed a high-fat "western" diet. Obesity (Silver Spring) 2010, 18(10):1895-1901. doi: 10.1038/oby.2009.500.
48. Wilson C.R., Tran M.K., Salazar K.L., Young M.E., Taegtmeyer H. Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of wistar rats. Biochemical Journal 2007, 406(3):457-467. doi: BJ20070392.
49. Hoffmann F.W., Hashimoto A.S., Lee B.C., Rose A.H., Shohet R.V., Hoffmann P.R. Specific antioxidant selenoproteins are induced in the heart during hypertrophy. Archives of Biochemistry and Biophysics 2011, 512(1):38-44. 10.1016/j.abb.2011.05.007. 10.1016/j.abb.2011.05.007.
50. Berndt C., Lillig C.H., Holmgren A. Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. American Journal of Physiology - Heart and Circulatory Physiology 2007, 292(3):H1227-H1236. doi: 01162.2006. [pii] 10.1152/ajpheart.01162.2006.
51. Curtis J.M., Hahn W.S., Stone M.D., Inda J.J., Droullard D.J., Kuzmicic J.P., et al. Protein carbonylation and adipocyte mitochondrial function. Journal of Biological Chemistry 2012, 287(39):32967-32980. doi: 10.1074/jbc.M112.400663.
52. Frohnert B.I., Bernlohr D.A. Protein carbonylation, mitochondrial dysfunction, and insulin resistance. Advances in Nutrition 2013, 4(2):157-163. doi: 10.3945/an.112.003319.
53. Hill B.G., Dranka B.P., Zou L., Chatham J.C., Darley-Usmar V.M. Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenal. Biochemical Journal 2009, 424(1):99-107. 10.1042/BJ20090934.
54. Fisher-Wellman K.H., Mattox T.A., Thayne K., Katunga L.A., La Favor J.D., Neufer P.D., et al. Novel role for thioredoxin reductase-2 in mitochondrial redox adaptations to obesogenic diet and exercise in heart and skeletal muscle. Journal of Physiology 2013, 591(Pt 14):3471-3486. 10.1113/jphysiol.2013.254193. 10.1113/jphysiol.2013.254193.
55. Rindler P.M., Plafker S.M., Szweda L.I., Kinter M. High dietary fat selectively increases catalase expression within cardiac mitochondria. Journal of Biological Chemistry 2013, 288(3):1979-1990. doi: 10.1074/jbc.M112.412890.
56. Bhatt N.M., Aon M.A., Tocchetti C.G., Shen X., Dey S., Ramirez-Correa G., et al. Restoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose. American Journal of Physiology - Heart and Circulatory Physiology 2015, 308(4):H291-H302. doi: 10.1152/ajpheart.00378.2014.
57. Xie J., Mendez J.D., Mendez-Valenzuela V., Aguilar-Hernandez M.M. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signaling 2013, 25(11):2185-2197. 10.1016/j.cellsig.2013.06.013.
58. Fritz G. RAGE: a single receptor fits multiple ligands. Trends in Biochemical Sciences 2011, 36(12):625-632. 10.1016/j.tibs.2011.08.008. 10.1016/j.tibs.2011.08.008.
59. Thorpe S.R., Baynes J.W. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 2003, 25(3-4):275-281. 10.1007/s00726-003-0017-9.
60. Biernacka A., Dobaczewski M., Frangogiannis N.G. TGF-beta signaling in fibrosis. Growth Factors 2011, 29(5):196-202. 10.3109/08977194.2011.595714.
61. Dobaczewski M., Gonzalez-Quesada C., Frangogiannis N.G. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. Journal of Molecular and Cellular Cardiology 2010, 48(3):504-511. http://dx.doi.org/10.1016/j.yjmcc.2009.07.015. 10.1016/j.yjmcc.2009.07.015.
62. Frangogiannis N.G. Matricellular proteins in cardiac adaptation and disease. Physiological Reviews 2012, 92(2):635-688. 10.1152/physrev.00008.2011. 10.1152/physrev.00008.2011.
63. Anderson E.J., Kypson A.P., Rodriguez E., Anderson C.A., Lehr E.J., Neufer P.D. Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. Journal of the American College of Cardiology 2009, 54(20):1891-1898. doi: S0735-1097(09)02758-2 [pii] 10.1016/j.jacc.2009.07.031.
64. LoPachin R.M., Gavin T. Molecular mechanisms of aldehyde toxicity: a chemical perspective. Chemical Research in Toxicology 2014, 27(7):1081-1091. doi: 10.1021/tx5001046.
65. Behring J.B., Kumar V., Whelan S.A., Chauhan P., Siwik D.A., Costello C.E., et al. Does reversible cysteine oxidation link the western diet to cardiac dysfunction?. FASEB Journal 2014, 28(5):1975-1987. doi: 10.1096/fj.13-233445.
66. Liang H., Ran Q., Jang Y.C., Holstein D., Lechleiter J., McDonald-Marsh T., et al. Glutathione peroxidase 4 differentially regulates the release of apoptogenic proteins from mitochondria. Free Radical Biology and Medicine 2009, 47(3):312-320. 10.1016/j.freeradbiomed.2009.05.012.
67. Liang H., Yoo S.E., Na R., Walter C.A., Richardson A., Ran Q. Short form glutathione peroxidase 4 is the essential isoform required for survival and somatic mitochondrial functions. Journal of Biological Chemistry 2009, 284(45):30836-30844. 10.1074/jbc.M109.032839.
68. Cole-Ezea P., Swan D., Shanley D., Hesketh J. Glutathione peroxidase 4 has a major role in protecting mitochondria from oxidative damage and maintaining oxidative phosphorylation complexes in gut epithelial cells. Free Radical Biology and Medicine 2012, 53(3):488-497. 10.1016/j.freeradbiomed.2012.05.029. 10.1016/j.freeradbiomed.2012.05.029.
69. Baseler W.A., Dabkowski E.R., Jagannathan R., Thapa D., Nichols C.E., Shepherd D.L., et al. Reversal of mitochondrial proteomic loss in type 1 diabetic heart with overexpression of phospholipid hydroperoxide glutathione peroxidase. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2013, 304(7):R553-R565. 10.1152/ajpregu.00249.2012.
70. Dabkowski E.R., Williamson C.L., Hollander J.M. Mitochondria-specific transgenic overexpression of phospholipid hydroperoxide glutathione peroxidase (GPx4) attenuates ischemia/reperfusion-associated cardiac dysfunction. Free Radical Biology and Medicine 2008, 45(6):855-865. 10.1016/j.freeradbiomed.2008.06.021. 10.1016/j.freeradbiomed.2008.06.021.
71. Conrad M. Transgenic mouse models for the vital selenoenzymes cytosolic thioredoxin reductase, mitochondrial thioredoxin reductase and glutathione peroxidase 4. Biochimica et Biophysica Acta 2009, 1790(11):1575-1585. 10.1016/j.bbagen.2009.05.001.
72. Li Q., Sadhukhan S., Berthiaume J.M., Ibarra R.A., Tang H., Deng S., et al. 4-hydroxy-2(E)-nonenal (HNE) catabolism and formation of HNE adducts are modulated by beta oxidation of fatty acids in the isolated rat heart. Free Radical Biology and Medicine 2013, 58:35-44. 10.1016/j.freeradbiomed.2013.01.005.
73. Anderson E.J., Rodriguez E., Anderson C.A., Thayne K., Chitwood W.R., Kypson A.P. Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways. American Journal of Physiology - Heart and Circulatory Physiology 2011, 300(1):H118-H124. 10.1152/ajpheart.00932.2010.
74. Lashin O.M., Szweda P.A., Szweda L.I., Romani A.M. Decreased complex II respiration and HNE-modified SDH subunit in diabetic heart. Free Radical Biology and Medicine 2006, 40(5):886-896. 10.1016/j.freeradbiomed.2005.10.040.
75. Sverdlov A.L., Elezaby A., Behring J.B., Bachschmid M.M., Luptak I., Tu V.H., et al. High fat, high sucrose diet causes cardiac mitochondrial dysfunction due in part to oxidative post-translational modification of mitochondrial complex II. Journal of Molecular and Cellular Cardiology 2015, 78:165-173. 10.1016/j.yjmcc.2014.07.018.
76. Loscalzo J. Keshan disease, selenium deficiency, and the selenoproteome. New England Journal of Medicine 2014, 370(18):1756-1760. 10.1056/NEJMcibr1402199.
77. Stanley W.C., Dabkowski E.R., Ribeiro R.F., O'Connell K.A. Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. Circulation Research 2012, 110(5):764-776. 10.1161/CIRCRESAHA.111.253104. 10.1161/CIRCRESAHA.111.253104.
78. Ghosh S., Rodrigues B. Cardiac cell death in early diabetes and its modulation by dietary fatty acids. Biochimica et Biophysica Acta 2006, 1761(10):1148-1162. 10.1016/j.bbalip.2006.08.010.
79. Borisov A.B., Ushakov A.V., Zagorulko A.K., Novikov N.Y., Selivanova K.F., Edwards C.A., et al. Intracardiac lipid accumulation, lipoatrophy of muscle cells and expansion of myocardial infarction in type 2 diabetic patients. Micron 2008, 39(7):944-951. 10.1016/j.micron.2007.11.002.
80. Sharma S., Adrogue J.V., Golfman L., Uray I., Lemm J., Youker K., et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB Journal 2004, 18(14):1692-1700. doi: 18/14/1692 [pii] 10.1096/fj.04-2263com.
81. Stanley W.C., Recchia F.A. Lipotoxicity and the development of heart failure: moving from mouse to man. Cell Metabolism 2010, 12(6):555-556. S1550-4131(10)00408-0 [pii] 10.1016/j.cmet.2010.11.016.
82. Opie L.H., Knuuti J. The adrenergic-fatty acid load in heart failure. Journal of the American College of Cardiology 2009, 54(18):1637-1646. 10.1016/j.jacc.2009.07.024; 10.1016/j.jacc.2009.07.024.
83. Hill B.G., Haberzettl P., Ahmed Y., Srivastava S., Bhatnagar A. Unsaturated lipid peroxidation-derived aldehydes activate autophagy in vascular smooth-muscle cells. Biochemical Journal 2008, 410(3):525-534. 10.1042/BJ20071063.
84. Okada K., Wangpoengtrakul C., Osawa T., Toyokuni S., Tanaka K., Uchida K. 4-hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. identification of proteasomes as target molecules. Journal of Biological Chemistry 1999, 274(34):23787-23793.
85. Imai H. Biological significance of lipid hydroperoxide and its reducing enzyme, phospholipid hydroperoxide glutathione peroxidase, in mammalian cells. Yakugaku Zasshi 2004, 124(12):937-957.
86. Nakamura T., Imai H., Tsunashima N., Nakagawa Y. Molecular cloning and functional expression of nucleolar phospholipid hydroperoxide glutathione peroxidase in mammalian cells. Biochemical and Biophysical Research Communications 2003, 311(1):139-148.
87. Sneddon A.A., Wu H.C., Farquharson A., Grant I., Arthur J.R., Rotondo D., et al. Regulation of selenoprotein GPx4 expression and activity in human endothelial cells by fatty acids, cytokines and antioxidants. Atherosclerosis 2003, 171(1):57-65.
88. Frustaci A., Francone M., Petrosillo N., Chimenti C. High prevalence of myocarditis in patients with hypertensive heart disease and cardiac deterioration. European Journal of Heart Failure 2013, 15(3):284-291. 10.1093/eurjhf/hfs169.
89. Aldini G., Orioli M., Rossoni G., Savi F., Braidotti P., Vistoli G., et al. The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in zucker obese rats. Journal of Cellular and Molecular Medicine 2011, 15(6):1339-1354. 10.1111/j.1582-4934.2010.01101.x. 10.1111/j.1582-4934.2010.01101.x.
90. Menini S., Iacobini C., Ricci C., Scipioni A., Blasetti Fantauzzi C., Giaccari A., et al. D-carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a western diet through reduction of carbonyl stress and inflammation. British Journal of Pharmacology 2012, 166(4):1344-1356. 10.1111/j.1476-5381.2012.01834. 10.1111/j.1476-5381.2012.01834.x.
91. Kass D.A., Shapiro E.P., Kawaguchi M., Capriotti A.R., Scuteri A., deGroof R.C., et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001, 104(13):1464-1470.
92. Little W.C., Zile M.R., Kitzman D.W., Hundley W.G., O'Brien T.X., Degroof R.C. The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure. Journal of Cardiac Failure 2005, 11(3):191-195. doi: S1071916404009017.
93. Tsujita K., Shimomura H., Kaikita K., Kawano H., Hokamaki J., Nagayoshi Y., et al. Long-term efficacy of edaravone in patients with acute myocardial infarction. Circulation Journal 2006, 70(7):832-837. doi: JST.JSTAGE/circj/70.832.
94. Anderson E.J., Efird J.T., Davies S.W., O'Neal W.T., Darden T.M., BS Thayne K.A., Katunga L.A., et al. Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillation. Journal of the American Heart Association (JAHA) 2014, 3(1):e000713. 10.1161/JAHA.113.000713.
95. Anderson E.J., Neufer P.D. Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation. American Journal of Physiology. Cell physiology 2006, 290(3):C844-C851.
96. Frezza C., Cipolat S., Scorrano L. Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nature Protocols 2007, 2(2):287-295. doi: nprot.2006.478.
97. Gostimskaya I., Galkin A. Preparation of highly coupled rat heart mitochondria. Journal of visualized experiments 2010, (43). pii: 2202. doi(43):10.3791/2202.
98. Merry T.L., Tran M., Stathopoulos M., Wiede F., Fam B.C., Dodd G.T., et al. High-fat-fed obese glutathione peroxidase 1-deficient mice exhibit defective insulin secretion but protection from hepatic steatosis and liver damage. Antioxid Redox Signal 2014 May 10, 20(14):2114-2129.
99. Kang L., Dai C., Lustig M.E., Bonner J.S., Mayes W.H., Mokshagundam S., et al. Heterozygous SOD2 deletion impairs glucose-stimulated insulin secretion, but not insulin action, in high-fat-fed mice. Diabetes 2014 Nov, 63(11):3699-3710.
100. Kendig E.L., Chen Y., Krishan M., Johansson E., Schneider S.N., Genter M.B., et al. Lipid metabolism and body composition in Gclm(-/-) mice. Toxicology and Applied Pharmacology 2011 Dec 15, 257(3):338-348.
101. Li Q., Tomcik K., Zhang S., Puchowicz M.A., Zhang G.F. Dietary regulation of catabolic disposal of 4-hydroxynonenal analogs in rat liver. Free Radical Biology and Medicine 2012 Mar 15, 52(6):1043-1053.
102. Aldini G., Carini M., Yeum K.J., Vistoli G. Novel molecular approaches for improving enzymatic and nonenzymatic detoxification of 4-hydroxynonenal: toward the discovery of a novel class of bioactive compounds. Free Radical Biology and Medicine 2014 Apr, 69:145-156.